Cogent Biosciences (COGT) FCF Margin (2017 - 2020)
Cogent Biosciences (COGT) recorded quarterly FCF Margin of 3290.71% in Q3 2020, down 108.73% quarter-over-quarter from 1576.52% in Q2 2020, and down 229218.0% on a YoY basis from N/an in Q4 2019.
Cogent Biosciences (COGT) FCF Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences' FCF Margin history runs 4 years deep, the most recent figure standing at 3290.71% for Q3 2020.
- In Q3 2020, FCF Margin fell 229218.0% year-over-year to 3290.71%; the TTM figure through Dec 2020 stood at 455.47% (down 27081.0% YoY), while the FY2020 annual figure was 455.47%, down 27081.0% from the prior year.
- FCF Margin was 3290.71% for Q3 2020 at Cogent Biosciences, down from 1576.52% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 55.32% in Q4 2019 to a low of 3290.71% in Q3 2020.
- Historically, FCF Margin has averaged 633.47% across 4 years, with a median of 364.37% in 2018.
- Biggest YoY gain for FCF Margin was 26638 bps in 2020; the steepest drop was 229218 bps in 2020.
- A 4-year view of FCF Margin shows it stood at 309.75% in 2017, then climbed by 23 bps to 237.06% in 2018, then soared by 77 bps to 55.32% in 2019, then sank by 5848 bps to 3290.71% in 2020.
- The last three FCF Margin figures came in at 3290.71% (Q3 2020), 1576.52% (Q2 2020), and 112.26% (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -3,290.71% |
| Jun 30, 2020 | -1,576.52% |
| Mar 31, 2020 | -112.26% |
| Dec 31, 2019 | -55.32% |
| Sep 30, 2019 | -998.53% |
| Jun 30, 2019 | -361.50% |
| Mar 31, 2019 | -378.64% |
| Dec 31, 2018 | -237.06% |
| Sep 30, 2018 | -393.69% |
| Jun 30, 2018 | -473.35% |
| Mar 31, 2018 | -364.37% |
| Dec 31, 2017 | -309.75% |
| Sep 30, 2017 | -247.45% |
| Jun 30, 2017 | -287.54% |
| Mar 31, 2017 | -415.33% |